Client Acceptability for Integrating Antiretroviral Therapy in Methadone Maintenance Therapy Clinics in Sichuan, China.
Using methadone maintenance therapy (MMT) clinics to deliver antiretroviral therapy (ART) has proven to be effective for promoting treatment initiation and adherence in drug users living with HIV.



The objective of this study was to investigate the HIV-positive client acceptability of integrated ART services and to identify the reasons for and factors associated with service acceptability.



A total of 86 HIV-positive MMT clients were recruited from 12 MMT clinics in Sichuan Province, China. They participated in a cross-sectional survey that queried their willingness to receive seven different types of MMT-based ART services. The reasons for their willingness/unwillingness to accept these services were documented. The association between service acceptability and background characteristics was examined.



The most accepted integrated services were ART-related counseling (75.6%) and referral (73.2%). Concerns regarding the provider's lack of ART expertise and confidentiality issues were common barriers for the acceptance of MMT-based ART services. A trust relationship with MMT providers was a reason for service acceptance. Service acceptability was associated with a poorer perceived health status. Conclusions/Importance: ART-related services, based on the client perspective, can be delivered at MMT clinics. However, service provider training and the protection of confidentiality must be strengthened for the effective implementation of integrated service delivery.
a Semel Institute for Neuroscience and Human Behavior , University of California at Los Angeles , Los Angeles , California , USA.
Chunqing
C
Lin
a Semel Institute for Neuroscience and Human Behavior , University of California at Los Angeles , Los Angeles , California , USA.
Li
L
Li
b National Center for AIDS Prevention and Control , Chinese Center for Disease Control and Prevention , Beijing , China.
Xiaobin
X
Cao
D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D002681:China; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006556:Heroin Dependence / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D008875:Middle Aged; D058850:Opiate Substitution Treatment / Q000379:methods*; D017060:Patient Satisfaction; D016896:Treatment Outcome
D044966:Anti-Retroviral Agents; D008691:Methadone
Acceptability; China; antiretroviral therapy; methadone maintenance therapy; service integration
J Int AIDS Soc. 2015 Jul 21;18:19936
26202669
Addiction. 2015 Jan;110 Suppl 1:51-60
25533864
Drug Alcohol Depend. 2011 Jan 15;113(2-3):192-9
20832196
Int J STD AIDS. 2010 Mar;21(3):161-5
20071440
Lancet Infect Dis. 2011 Jul;11(7):516-24
21600849
Addiction. 2010 May;105(5):907-13
20331553
London J Prim Care (Abingdon). 2012;5(1):29-34
25949664
J Drug Issues. 2012 Apr 1;42(2):null
24244048
J Int AIDS Soc. 2013 Apr 26;16:18000
23621903
BMC Infect Dis. 2015 Apr 18;15:193
25927573
Qual Life Res. 2004 Apr;13(3):601-10
15130024
J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S134-41
17133197
Lancet. 2007 Feb 24;369(9562):679-90
17321313
Drug Alcohol Depend. 2014 Jan 1;134:106-14
24128379
AIDS Behav. 2014 Apr;18(4):740-6
23918244
Lancet. 2010 Jul 31;376(9738):355-66
20650513
Int J Drug Policy. 2014 Nov;25(6):1066-70
24939555
Acta Med Indones. 2009 Jul;41 Suppl 1:23-7
19920294
Trop Med Int Health. 2015 Apr;20(4):430-47
25583302
J Urban Health. 2012 Oct;89(5):794-801
22547327
Health Policy Plan. 2013 Oct;28(7):681-91
23197431
Drug Alcohol Depend. 2012 Oct 1;125(3):260-6
22436971
Addiction. 2015 Jan;110 Suppl 1:40-50
25533863
J Int AIDS Soc. 2014 May 16;17:18911
24836775
Cad Saude Publica. 2006 Apr;22(4):705-18
16612417
Clin Infect Dis. 2003 Jun 15;36(12):1572-6
12802758